Search research articles
Contact Us
Filters
Showing results (11-20 of 22) with videos related to
Page
of 3
Sort By:
Integrated Environmental Assessment and Management
|
November 23, 2020
Facilitating the Decision-Making Process After a Nuclear Accident: Case Studies in the Netherlands and Slovakia
Esther D van Asselt, Chris Jw Twenhöfel, Tatiana Duranova, et al.
Annals of Diagnostic Pathology
|
April 18, 2018
The knockdown of the mediator complex subunit MED30 suppresses the proliferation and migration of renal cell carcinoma cells
Isabella Syring, Richard Weiten, Tim Müller, et al.
Anticancer Research
|
December 1, 2017
The Contrasting Role of the Mediator Subunit MED30 in the Progression of Bladder Cancer
Isabella Syring, Richard Weiten, Tim Müller, et al.
Oncology Letters
|
August 22, 2018
The knockdown of the Mediator complex subunit MED15 restrains urothelial bladder cancer cells' malignancy
Isabella Syring, Richard Weiten, Tim Müller, et al.
Cancer Biomarkers : Section a of Disease Markers
|
February 6, 2018
The Mediator complex subunit MED15, a promoter of tumour progression and metastatic spread in renal cell carcinoma
Richard Weiten, Tim Müller, Doris Schmidt, et al.
Clinical Genitourinary Cancer
|
November 19, 2018
Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma
Tim Müller, Yuri Tolkach, David Stahl, et al.
Oncotarget
|
February 9, 2018
<i>PD-L1</i> (<i>CD274</i>) and <i>PD-L2</i> (<i>PDCD1LG2</i>) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas
Alina Franzen, Timo J Vogt, Tim Müller, et al.
Oncotarget
|
September 9, 2017
PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
Tim Müller, Martin Braun, Dimo Dietrich, et al.
Anticancer Research
|
February 27, 2022
Programmed Cell Death Ligand-1 (PDL-1) Correlates With Tumor Infiltration by Immune Cells and Represents a Promising Target for Immunotherapy in Endometrial Cancer
Thomas Hecking, Thore Thiesler, Janina Halbe, et al.
Translational Oncology
|
December 19, 2016
MTSS1 is epigenetically regulated in glioma cells and inhibits glioma cell motility
Daniel Luxen, Gerrit H Gielen, Anke Waha, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 22) with videos related to
Sort By:
Page
of 3
Integrated Environmental Assessment and Management
|
November 23, 2020
Facilitating the Decision-Making Process After a Nuclear Accident: Case Studies in the Netherlands and Slovakia
Esther D van Asselt, Chris Jw Twenhöfel, Tatiana Duranova, et al.
Annals of Diagnostic Pathology
|
April 18, 2018
The knockdown of the mediator complex subunit MED30 suppresses the proliferation and migration of renal cell carcinoma cells
Isabella Syring, Richard Weiten, Tim Müller, et al.
Anticancer Research
|
December 1, 2017
The Contrasting Role of the Mediator Subunit MED30 in the Progression of Bladder Cancer
Isabella Syring, Richard Weiten, Tim Müller, et al.
Oncology Letters
|
August 22, 2018
The knockdown of the Mediator complex subunit MED15 restrains urothelial bladder cancer cells' malignancy
Isabella Syring, Richard Weiten, Tim Müller, et al.
Cancer Biomarkers : Section a of Disease Markers
|
February 6, 2018
The Mediator complex subunit MED15, a promoter of tumour progression and metastatic spread in renal cell carcinoma
Richard Weiten, Tim Müller, Doris Schmidt, et al.
Clinical Genitourinary Cancer
|
November 19, 2018
Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma
Tim Müller, Yuri Tolkach, David Stahl, et al.
Oncotarget
|
February 9, 2018
<i>PD-L1</i> (<i>CD274</i>) and <i>PD-L2</i> (<i>PDCD1LG2</i>) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas
Alina Franzen, Timo J Vogt, Tim Müller, et al.
Oncotarget
|
September 9, 2017
PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
Tim Müller, Martin Braun, Dimo Dietrich, et al.
Anticancer Research
|
February 27, 2022
Programmed Cell Death Ligand-1 (PDL-1) Correlates With Tumor Infiltration by Immune Cells and Represents a Promising Target for Immunotherapy in Endometrial Cancer
Thomas Hecking, Thore Thiesler, Janina Halbe, et al.
Translational Oncology
|
December 19, 2016
MTSS1 is epigenetically regulated in glioma cells and inhibits glioma cell motility
Daniel Luxen, Gerrit H Gielen, Anke Waha, et al.
Page
of 3